Tumorigenic and prognostic significance of rassf1a expression in low-grade (WHO Grade 1 and Grade 2) nonmuscle-invasive bladder cancer

Urology

Volumn 79, Issue 6, 2012, Pages 1411.e1-1411.e6

  Ha, Yun Sok ^a,b   Jeong, Pildu ^a   Kim, Ji Sang ^a,c   Kwon, Whi An ^a,d   Kim, Isaac Yi ^b   Yun, Seok Joong ^a   Kim, Gi Young ^e   Choi, Yung Hyun ^f   Moon, Sung Kwon ^g   Kim, Wun Jae ^a,c  

^a Chungbuk National University College of Medicine   (South Korea)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Chungbuk National University   (South Korea)

^d Wonkwang University   (South Korea)

^e Jeju National University   (South Korea)

^f Dong Eui University   (South Korea)

^g Chungju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER TISSUE; CARCINOGENICITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84862805811     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.01.042     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics CA Cancer J Clin 60 2010 277 300
2. Y.K. Kim, W.J. Kim Epigenetic markers as promising prognosticators for bladder cancer Int J Urol 16 2009 17 22
3. E.J. Kim, Y.S. Lee, Y.J. Kim Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer Urology 75 2010 e9 e13
4. S. Thaler, P.S. Hähnel, A. Schad RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt Cancer Res 69 2009 1748 1757
5. L. van der Weyden, K.K. Tachibana, M.A. Gonzalez The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis Mol Cell Biol 25 2005 8356 8367 (Pubitemid 41263023)
6. M.G. Lee, H.Y. Kim, D.S. Byun Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma Cancer Res 61 2001 6688 6692
7. M.W. Chan, L.W. Chan, N.L. Tang Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients Int J Cancer 104 2003 611 616 (Pubitemid 36337261)
8. J.W. Catto, A.R. Azzouzi, I. Rehman Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma J Clin Oncol 23 2005 2903 2910 (Pubitemid 46224108)
9. X.R. Wu Urothelial tumorigenesis: a tale of divergent pathways Nat Rev Cancer 5 2005 713 725
10. M. Babjuk, W. Oosterlinck, R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
11. F.L. Greene The American Joint Committee on Cancer: updating the strategies in cancer staging Bull Am Coll Surg 87 2002 13 15
12. M.C. Hall, S.S. Chang, G. Dalbagni Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314 2330 (Pubitemid 350080987)
13. J.M. Bland, D.G. Altman Transformations, means, and confidence intervals Bmj 312 1996 1079-1079
14. A. Agathanggelou, W.N. Cooper, F. Latif Role of the Ras-association domain family 1 tumor suppressor gene in human cancers Cancer Res 65 2005 3497 3508 (Pubitemid 40616319)
15. X. Liu, X. Dai, B. Wu Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line Urol Int 82 2009 108 112
16. M.S. Song, D.S. Lim Control of APC-Cdc20 by the tumor suppressor RASSF1A Cell Cycle 3 2004 574 576 (Pubitemid 40278192)
17. L. Shivakumar, J. Minna, T. Sakamaki The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation Mol Cell Biol 22 2002 4309 4318 (Pubitemid 34556598)
18. S. Baksh, S. Tommasi, S. Fenton The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death Mol Cell 18 2005 637 650 (Pubitemid 40804800)
19. M.D. Vos, A. Dallol, K. Eckfeld The RASSF1A tumor suppressor activates Bax via MOAP-1 J Biol Chem 281 2006 4557 4563 (Pubitemid 43847713)
20. M.D. Vos, C.A. Ellis, A. Bell Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis J Biol Chem 275 2000 35669 35672
21. R. Maruyama, S. Toyooka, K.O. Toyooka Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features Cancer Res 61 2001 8659 8663 (Pubitemid 34013873)
22. S. Jarmalaite, F. Jankevicius, K. Kurgonaite Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer Oncology 75 2008 145 151
23. J. Hu, H. Li, T. Shi Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor J Huazhong Univ Sci Technolog Med Sci 28 2008 182 184
24. R.J. Sylvester, A.P. van der Meijden, W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 475 (Pubitemid 43259554)
25. B.W. van Rhijn, M. Burger, Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430 442
26. S.F. Shariat, C. Zippe, G. Lüdecke Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder J Urol 173 2005 1518 1525 (Pubitemid 40524761)
27. W.J. Kim, E.J. Kim, S.K. Kim Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer Mol Cancer 9 2010 3 11
28. Y.J. Kim, Y.S. Ha, S.K. Kim Gene signatures for the prediction of response to bacillus Calmette-Guérin immunotherapy in primary pT1 bladder cancers Clin Cancer Res 16 2010 2131 2137
29. B.W. van Rhijn, I. Lurkin, F. Radvanyi The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate Cancer Res 61 2001 1265 1268 (Pubitemid 34292538)
30. Y.S. Ha, C. Yan, P. Jeong GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer J Korean Med Sci 26 2011 231 236